A therapeutic alternative for haemophiliacs with inhibitors.
Schulman
S
S
Department of Internal Medicine, Karolinska Hospital, Stockholm, Sweden.
D005164:Factor IX / Q000276:immunology; D005169:Factor VIII / Q000276:immunology; D015942:Factor VIIa / Q000627:therapeutic use*; D005173:Factor XI Deficiency / Q000188:drug therapy / Q000276:immunology; D006467:Hemophilia A / Q000188:drug therapy* / Q000276:immunology; D002836:Hemophilia B / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007518:Isoantibodies; D011994:Recombinant Proteins / Q000627:therapeutic use
D007518:Isoantibodies; D011994:Recombinant Proteins; D005169:Factor VIII; D005164:Factor IX; D015942:Factor VIIa